|
C9ORF21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.589800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.680600E-01 |
| Normal-vs-Stage2 |
7.439600E-01 |
| Normal-vs-Stage3 |
2.649800E-01 |
| Normal-vs-Stage4 |
1.256750E-01 |
| Stage1-vs-Stage2 |
2.871800E-01 |
| Stage1-vs-Stage3 |
3.270500E-02 |
| Stage1-vs-Stage4 |
8.943100E-03 |
| Stage2-vs-Stage3 |
5.055000E-01 |
| Stage2-vs-Stage4 |
1.409240E-01 |
| Stage3-vs-Stage4 |
3.363400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.157400E-01 |
| Normal-vs-AfricanAmerican |
8.195600E-01 |
| Normal-vs-Asian |
3.269400E-01 |
| Caucasian-vs-AfricanAmerican |
4.491800E-01 |
| Caucasian-vs-Asian |
4.913000E-01 |
| AfricanAmerican-vs-Asian |
3.874000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.226800E-01 |
| Normal-vs-Female |
5.861800E-01 |
| Male-vs-Female |
1.541560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.816800E-01 |
| Normal-vs-Extreme_Weight |
6.228600E-01 |
| Normal-vs-Obese |
6.366200E-01 |
| Normal-vs-Extreme_Obese |
4.765200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.358200E-01 |
| Normal_Weight-vs-Obese |
4.928600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.851200E-01 |
| Extreme_Weight-vs-Obese |
2.862000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.409000E-01 |
| Obese-vs-Extreme_Obese |
4.442400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.313400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.995400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.703790E-01 |
| Normal-vs-Age(81-100Yrs) |
9.163400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.877600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.243000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.234000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.359920E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.293000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.224000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.029200E-01 |
| Normal-VS-Type2 PRCC |
4.685000E-01 |
| Normal-VS-KIRP CIMP |
3.379900E-03 |
| Normal-VS-Unclassified PRCC |
9.380800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.262400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.810510E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.612200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.375700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.993000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.642080E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.101000E-01 |
| Normal-vs-N1 |
4.197000E-03 |
| Normal-vs-N2 |
8.454000E-01 |
| N0-vs-N1 |
2.976700E-03 |
| N0-vs-N2 |
7.150400E-01 |
| N1-vs-N2 |
2.774600E-01 |
|
|
